A novel method of identifying cholera enterotoxin (CT)-producing Vibrio cholerae serogroups O1 and O139 was developed. The method uses degradation of NAD as a specific biochemical marker for the CT-producing strains. The substrate NAD at a concentration of 100 mol/liter was markedly degraded when it was incubated at 37؇C for 2 h with the CT-producing strains at a final cell density equivalent to that of a twofold dilution of a McFarland no. 1 standard. NAD degradation was monitored by an enzyme-amplified color development assay. Subsequent tests conducted with a total of 119 strains of V. cholerae, including both clinical and environmental isolates, confirmed a significant correlation between NAD degradation and CT production for all V. cholerae strains belonging to serogroups O1 and O139. Since 2 of 11 non-O1, non-O139 V. cholerae strains not carrying the CT gene degraded NAD, serotyping of the strains prior to the test is recommended.
Vibrio cholerae is a major gastrointestinal pathogen that causes serious morbidity and mortality worldwide (5, 7) . Until recently only the serogroup O1 strain producing cholera enterotoxin (CT) was known to cause the disease. However, recently it was found that the CT-producing strain responsible for the cholera epidemic occurring on the Indian subcontinent in 1992 belonged to serogroup O139 (2, 13) . This epidemic has increased the awareness of CT as a major virulence factor for enteropathogenic V. cholerae. A rapid and simple CT detection method is therefore essential not only for an earlier diagnosis but also for efficient disease control. The methods used to detect CT in clinical microbiological laboratories have so far been based on the immunological property of CT (i.e., a reversed passive latex agglutination assay [RPLA] [10] ) or a specific DNA sequence encoding CT in the bacterial chromosome (DNA probe-based hybridization [8, 15] and PCR assays [4, 9] ). RPLA, however, requires at least 38 h (consisting of 18 h of overnight culture and 20 h of reaction time for latex agglutination) before results are available, and the latter, although relatively rapid, requires expensive facilities and is thus not suitable for routine use in a small laboratory. Both methods thus have limited use in practice when dealing with large numbers of clinical or environmental isolates within a relatively short time.
CT is composed of two subunits, subunits A and B, which are responsible for its enzymatic and cell-binding activities, respectively (3). Subunit A catalyzes ADP ribosylation of guanylnucleotide-binding regulatory proteins within the host's target cells, thereby increasing the level of intracellular cyclic AMP (6) . ADP ribosylation apparently involves degradation (or hydrolysis) of NAD, which is catalyzed by the ADP-ribosyltransferase activity of subunit A (11) . In this context, subunit A has NAD glycohydrolase (NADase) activity, splitting NAD into ADP-ribose and nicotinamide (14) . We have thus postulated that CT-producing strains are capable of degrading NAD. In this report, we describe a novel method that uses NAD degradation as a biochemical marker for identifying CT-producing V. cholerae O1 (El Tor biogroup) and O139 (synonym Bengal) strains.
Development of assay system. We used seven strains of V. cholerae. These included three CT-producing O1 strains (strains K-10397 and K-10401 [El Tor Ogawa type] and strain K-10402 [El Tor Inaba type]), one CT-producing O139 strain (strain MO 45, which was a gift from T. Shimada of the National Health Institute, Tokyo, Japan), and three non-CT-producing O1 strains (strains K-10254, K-10264, and K-10437 [El Tor Ogawa type]). Prior to the experiment, the strains' ability to produce CT was checked by both RPLA (10) and PCR assay (9) . An overnight culture of each strain grown in heart infusion (HI) broth (Difco Laboratories, Detroit, Mich.) was inoculated onto an HI agar (Difco) plate. The plate was then incubated aerobically at 30ЊC for 18 h. After incubation, the growth was harvested and was suspended in 2 ml of 0.01 M phosphatebuffered saline (PBS; pH 7.0) to make bacterial suspensions with a range of final cell densities from densities equivalent to a McFarland no. After incubation, the concentration of NAD remaining in each well was measured by a method based on that described by Pugh et al. (12) . Briefly, a 100-l volume of freshly prepared color-amplifying solution containing 4 ml of ethanol, 0.1 g of semicarbazide hydrochloride (Wako Pure Chemical Ind., Ltd., Osaka, Japan), 20 mg of 3-(4-iodophenyl)-2-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (INT; Merck, Darmstadt, Germany), 0.3 mg of phenazine methosulfate (PMS; Wako), 40 l of Tween 80 (Sigma Chemical Company, St. Louis, Mo.), and 200 U of alcohol dehydrogenase (ADH; Oriental) in 100 ml of 0.2 M Tris solution (pH 8.0) was added to each well containing the sample mixture, the contents of the wells were mixed gently with a microplate mixer, and the plates were incubated at 37ЊC for 10 min. During incubation, NAD, if any, is reduced to NADH 2 by the action of ADH in the presence of ethanol. The reduction of PMS to PMSH 2 regenerates NAD and, while being oxidized again to PMS, reduces INT to yield a colored product. This multicycle chain reaction thus amplifies the sensitivity of the test, in which the degree of amplification depends on the relative concentration of NAD present in the system. The reaction was stopped by the addition of 50 l of 0.27 M sulfuric acid to the well. The A 492 for each well was subsequently read with a microplate spectrophotometer (model 450; Bio-Rad, Richmond, Calif.), in which a decrease in absorbance is interpreted as NAD degradation.
A preliminary test confirmed that the absorbance is directly proportional to the concentration of the substrate NAD over a concentration range of from 5 to 100 mol/liter and that this linear relationship is maintained even after a prolonged incubation (at least for 6 h; data not shown). Color development of the reaction mixture was also monitored visually in the test, in which the wells containing NAD at more than 80 mol/liter gave a distinct red color, while the ones containing NAD at a concentration of less than 30 mol/liter gave only a faint pink color.
NAD degradation, as indicated by a marked decrease in the A 492 (less than 0.4), was observed within 2 h in the wells containing CT-producing strains whose cell density was more than a twofold dilution of a McFarland no. 1 standard (Fig. 1a,  b , and c), while the degradation was not observed until 4 h of incubation in the wells containing bacterial cells at a density equivalent to the densities of four-to eightfold dilutions of a McFarland no. 1 standard (Fig. 1d and e) . The non-CT-producing strains with a cell density greater than that of a McFarland no. 1 standard degraded NAD after 4 h of incubation, but the degradation rate was much slower than that of the CTproducing strains (Fig. 1a and b) . The results indicated that CT-producing strains have much stronger NAD-degrading activity than non-CT-producing strains. This difference was easily detectable visually; the suspension with the CT-producing strains with a cell density equivalent to that of a twofold dilution of a McFarland no. 1 standard gave only a faint pink color in the well after 2 h of incubation (Fig. 1c) , in contrast to non-CT-producing strains, which gave a strong red color.
Large-scale screening. On the basis of the results described above, we further analyzed a total of 119 strains of V. cholerae, obtained clinically or environmentally during the period from 1988 to 1996, for their NAD-degrading activities. These included 11 CT-producing strains and 42 non-CT-producing strains, all belonging to the V. cholerae O1 El Tor type, and 9 CT-producing strains of V. cholerae O139. In addition, 11 strains of non-O1, non-O139 V. cholerae that did not produce CT were also tested for comparison. Fifty microliters of a fresh whole-cell suspension (with a density equivalent to that of a McFarland no. 1 standard; A 660 ϭ 0.17 Ϯ 0.01; ca. 3.0 ϫ 10 8 CFU/ml) was added to an equal volume of substrate solution (at a final concentration of 100 mol of NAD per liter in PBS [pH 7.0]) in a well of the plate, mixed thoroughly with a microplate mixer, and incubated at 37ЊC for up to 4 h. After 1, 2, and 4 h of incubation, NAD degradation was visually determined by the assay method described above, in which the strains giving only a pink color were judged to be NAD-degrading strains (Fig. 2) . All CT-producing strains (66 strains), including strains of the O1 and O139 types, yielded positive results for NAD degradation after 2 h of incubation (Table 1) , whereas only 2 non-CT-producing strains belonging to the V. cholerae O1 type became positive after 4 h of incubation. From these results, NAD degradation results should be read after 2 h of incubation of the mixture of bacterial cells and the substrate NAD at appropriate concentrations of a halfstrength of a McFarland no. 1 density standard and 100 M/ liter, respectively.
It has been demonstrated that Clostridium botulinum produces an ADP-ribosylating exotoxin (C3) which exhibits NADase activity, although the activity is very low (1). Thus, it is probable that the observed NAD degradation by V. cholerae is caused by the ADP-ribosylating CT. However, two of the non-O1, non-O139 strains that did not either produce CT or carry the CT gene also degraded NAD within 1 h (Table 1) . These strains had been isolated from the feces of patients with severe diarrhea. The evidence points to an alternative possibility that the observed NAD degradation was caused by a metabolic activity that is a phenotypic property independent of CT. Further study is necessary to determine how NAD is degraded by V. cholerae and whether this degradation property is associated with its pathogenicity.
The present study demonstrated that NAD degradation can be used as a reliable biochemical marker for the identification of CT-producing O1 and O139 V. cholerae strains. The assay method would be a useful clinical tool for a rapid and largescale screening for CT-positive strains. Since there were non-O1, non-O139 strains that were positive for NAD degradation but that did not carry the CT gene, it is highly recommended that the serotype of any isolate tentatively identified as V. cholerae be confirmed as O1 or O139 prior to the assay.
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